Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

6.25
+0.660011.81%
Post-market: 6.19-0.0600-0.96%16:44 EDT
Volume:1.97M
Turnover:12.08M
Market Cap:281.24M
PE:-2.88
High:6.30
Open:5.60
Low:5.58
Close:5.59
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:1.05
T/O Rate:11.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:1.06
PE(LYR):-3.32

Loading ...

OverviewCompanyNewsFilings

Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says

MT Newswires Live
·
Aug 12

Why Sionna Therapeutics (SION) Is Down 90.9% After Ending SION-719 Add-On To Trikafta Therapy

Simply Wall St.
·
Aug 12

Sionna Therapeutics price target lowered to $5 from $38 at Freedom Broker

TIPRANKS
·
Aug 11

Sionna Therapeutics Cut to Neutral from Buy by BTIG

Dow Jones
·
Aug 11

Sionna Therapeutics, Inc. : Btig Cuts to Neutral from Buy

THOMSON REUTERS
·
Aug 11

Sionna Therapeutics, Inc. : Jonestrading Cuts to Hold Rating

THOMSON REUTERS
·
Aug 11

Small U.S. Stocks Decrease; Sionna Therapeutics Posts Biggest Loss

Dow Jones
·
Aug 11

Sionna Therapeutics downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
Aug 11

Sionna Therapeutics: Hold Rating Maintained as Disappointing CF Data Drive Price Target Cut from $60 to $6

TIPRANKS
·
Aug 11

Sionna Therapeutics downgraded to Neutral from Buy at BTIG

TIPRANKS
·
Aug 11

Top Midday Decliners

MT Newswires Live
·
Aug 11

Sionna Therapeutics downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
Aug 11

Citizens downgrades Sionna Therapeutics as SION-719 miss questions NBD1 thesis

TIPRANKS
·
Aug 11

U.S. Stocks on the MOVE-Microsoft, Coastal Financial

Reuters
·
Aug 11

Sionna Therapeutics falls -92.0%

TIPRANKS
·
Aug 11

Why Sionna Therapeutics Stock is Crashing 92% to a Record Low

Dow Jones
·
Aug 11

Sionna Therapeutics downgraded to Market Perform from Outperform at Citizens

TIPRANKS
·
Aug 10

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

TIPRANKS
·
Aug 10

Top Midday Stories: Intel Offers $15 Billion of Common Stock; Microsoft to Ramp Up Production of Homegrown AI Chip

MT Newswires Live
·
Aug 10

Sionna Therapeutics downgraded to Market Perform from Strong Buy at Raymond James

TIPRANKS
·
Aug 10
More